InMed to Participate in Fireside Chat with Water Tower Research on May 23, 2023 at 1pm ET
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announce… Read More




